MicroHeal aims to revolutionize chronic disease management by integrating Digital Therapeutics (DTx) with drug therapy to address complex conditions like Functional Gastrointestinal Disorders (FGID). By combining personalized drug therapy with data-driven digital solutions, MicroHeal seeks to improve treatment outcomes, reduce symptoms, and enhance the overall quality of life for patients.
About Us
STAGE OF DEVELOPMENT - TRL 7
Enhance drug therapy by integrating digital therapeutics (Drug + DTx) to manage chronic conditions & disorders, using a hyper-personalized, data-driven approach. This aims to improve symptom severity, quality of life, and treatment efficacy, providing insights for better outcomes. Validation through rigorous randomized controlled trials (RCTs) is essential.
Brief about the mentorship or support they are seeking
- Clinical Validation & RCT Design
- Personalization & Data Analytics
- Regulatory Pathways for Combined Solutions
- Go-to-Market Strategy & Adoption
Our Collaborators
